Twice Yearly HIV Prevention Shot, Yeztugo, May Face Access Hurdles

The Food and Drug Administration approved lenacapavir (Yeztugo) in June as pre-exposure prophylaxis to reduce the risk of…

Continue Reading


News Source: www.forbes.com

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *